Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing: A-TRAIN

NCT05099978 is registered in ClinicalTrials.gov with National Cancer Center, Japan as lead sponsor.

NCT NCT05099978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05099978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing: A-TRAIN
Lead sponsor
National Cancer Center, Japan
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2021
Completion date
December 31, 2024
Enrollment
506 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, nasopharyngeal carcinoma, ovarian cancer, ovarian clear cell carcinoma, triple negative breast cancer